WAILEA, Hawaii — At Hawaiian Eye 2021, Andrew G. Lee, MD, outlines his SAVER list of steps ophthalmologists can take to identify and treat neurological pathologies.

WAILEA, Hawaii — At Hawaiian Eye 2021, Nancy S. Lurker, president and CEO of EyePoint Pharmaceuticals, discusses steps that can be taken to improve gender diversity in ophthalmology.

WAILEA, Hawaii — In patients with traumatic periorbital and orbital injuries, airway, breathing and circulation – the ABCs – need to be addressed first, before addressing ocular trauma.

WAILEA, Hawaii — At Hawaiian Eye 2021, Deborah G. Ristvedt, DO, discusses how to implement minimally invasive glaucoma surgery techniques in a surgical practice using the newest technologies.

WAILEA, Hawaii — “For those of you in retina or have retina in your practice I am sure this is a topic of conversation – the government is coming after anti-VEGF therapy from all directions,” said an expert in healthcare law.

WAILEA, Hawaii — At Hawaiian Eye 2021, Yari L. Mitchell, chief business development officer at AcuFocus, discusses her presentation at OSN’s Disruptive Innovations symposium here on the company and progress toward FDA approval of the IC-8 IOL.

WAILEA, Hawaii — Staffing disruptions, questions around telehealth and the vaccination status of office staff are questions practice managers are contending with a year into the COVID-19 pandemic.

WAILEA, Hawaii — One powerful cognitive tool for building resilience in the face of adversity is the ability to reframe negatives into positives, according to a speaker at Hawaiian Eye 2021.

WAILEA, Hawaii — While ophthalmologists internalize the lessons learned from the worst months of the pandemic in 2020, there is room for optimism that practice numbers are returning to pre-COVID levels.

WAILEA, Hawaii — Adverse reactions from soft tissue augmentation are usually mild, but oculoplastic specialists should be aware of potentially vision-threatening vascular compromise, according to a speaker at Hawaiian Eye 2021.